Pretzel Therapeutics mission is to develop groundbreaking therapies to reverse mitochondrial dysfunction through mitochondrial biology.
Pretzel Therapeutics's investors include ARCH Venture Partners, HealthCap, Google Ventures, Cambridge Innovation Capital, Invus.
Pretzel Therapeutics is headquartered in Waltham, United States.
Pretzel Therapeutics mission is to develop groundbreaking therapies to reverse mitochondrial dysfunction through mitochondrial biology.
Pretzel Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pretzel Therapeutics — Funding & Investors." VCBacked, July 2, 2025, https://www.vcbacked.co/company/pretzel-therapeutics. Accessed September 30, 2026.
VCBacked. (2025). Pretzel Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/pretzel-therapeutics
{{cite web |title=Pretzel Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/pretzel-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated